Open Book: Alert for prescribing error – dabigatran and enoxaparin (July 2017)

18 Jul 2017 | Adverse Events

This report alerts providers to adverse event cases reported to the Commission’s Adverse Events Learning Programme.

It highlights the risks when prescribers are unaware of the requirements for prescribing dabigatran or switching between enoxaparin (Clexane) and dabigatran (Pradaxa).

The requirements are different to when starting warfarin or switching between warfarin and enoxaparin.

Last updated 25/10/2021